Please enter the email address you registered with to access the event.
Presenters
Dr. Muhammad Alì Muslimani
Physician and Researcher,
University of Pavia and the Division of Infectious Diseases, Fondazione IRCCS Policlinico San Matteo, Pavia
Dr. Muhammad Alì Muslimani is a physician and researcher affiliated with the Department of Internal Medicine and Medical Therapy at the University of Pavia and the Division of Infectious Diseases at Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. His clinical and research interests encompass infectious and tropical diseases, with a particular focus on the diagnosis and management of complex infections and the provision of interdisciplinary patient care. His experience offers valuable insight into the role of targeted laboratory investigations in informing clinical decision-making, as well as the importance of timely, evidence-based antimicrobial treatment strategies.
Christer Malmberg, PhD
Chief Scientific Officer,
Gradientech
Christer Malmberg is a clinical microbiology and antimicrobial resistance researcher with extensive experience in rapid phenotypic antimicrobial susceptibility testing (AST). Since joining Gradientech in 2014, he has played a key role in the development, clinical evaluation and implementation of the company’s microfluidic rapid AST technology. His research focuses on accelerating reliable phenotypic susceptibility testing and understanding how earlier, clinically actionable results can support more timely antimicrobial treatment decisions. His work includes multicenter clinical evaluation of rapid AST, laboratory workflow implementation, multidrug-resistant Gram-negative infections and susceptibility testing of newer antibiotics such as cefiderocol. As Chief Scientific Officer, Christer provides scientific leadership in the continued development and clinical application of rapid AST technologies. He holds a PhD in Medical Cell Biology and an MSc in Molecular Biotechnology Engineering from Uppsala University.
Prof. Dr. Holger Rohde
Senior Physician and Deputy Director of the Institute of Medical Microbiology,
Virology and Hygiene University Medical Center Hamburg-Eppendorf (UKE)
Prof. Holger Rohde is a Senior Physician and Deputy Director of the Institute of Medical Microbiology, Virology and Hygiene at the University Medical Center Hamburg-Eppendorf (UKE), Germany, where he is also Professor of Molecular Medical Microbiology. His research spans antimicrobial resistance, hospital-acquired infections and the molecular pathogenesis of biofilm-associated infections, with expertise extending to multidrug-resistant Gram-negative pathogens and innovative diagnostic technologies. He has extensive experience in the clinical evaluation and implementation of rapid diagnostics, including rapid AST for Gram-negative bloodstream infections. Professor Rohde is currently ESCMID AMR Action Director, leading the AMR Action Subcommittee and contributing to the development and coordination of ESCMID's activities in antimicrobial resistance.